Amplion Archives - Page 3 of 5

Biomarkers triple clinical trial success rate, says report

May 26, 2016 | Biomarkers, News

Biomarkers triple clinical trial success rate, says report By Melissa Fassbender, 26-May-2016 A recent study of clinical drug development success rates found that biomarker-enabled drug programs are three times more likely to reach approval....

Amplion, BIO, and BioMedTracker release new report on ground breaking role biomarkers have in increasing Likelihood of Approval (LOA)

May 25, 2016 | Biomarkers, News

New Report from Amplion, BIO, and BioMedTracker examined ~10,000 clinical trials to make groundbreaking conclusion regarding biomarkers. Bend, Ore., May 25, 2016., May 25, 2016 – Amplion (developers of BiomarkerBaseTM), Biomedtracker, and BIO announces the...

Report suggests drug-approval rate now just 1-in-10

May 25, 2016 | News

This article was originally published on Boston Business Journal on May 25, 2016 by Don Seiffert A report released today by the biotech industry’s national trade group finds less than one of every 10 drugs that enter clinical trials is ultimately approved by the Food...

PR NewsWire: A New Report From Amplion: Companion Diagnostic Biomarker Trends.

May 4, 2016 | News

Trends in biomarker types and uses, test development, and drug enablement are described in this new report, along with a breakdown of the companies that are doing the most to advance precision medicine. 10:00 ET from Amplion Inc. BEND, Ore., May 4, 2016 /PRNewswire/...

Report: Companion Diagnostic Biomarker Trends Report

May 2, 2016 | News

Trends in biomarker types and uses, test development, and drug enablement are described in this new report, along with a breakdown of the companies that are doing the most to advance precision medicine. BEND, OR – May 3, 2016 – Amplion Inc., publisher of...

« Older Entries

Next Entries »